(1)
Helbig, G.; Bober, G.; Seweryn, M.; Wichary, R.; Tukiendorf, A.; Sedlak, L.; Oleksy, T.; Kyrcz-Krzemien, S. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. Mediterr J Hematol Infect Dis 2015, 7, e2015003.